Artwork

コンテンツは NeurologyLive® Mind Moments® によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、NeurologyLive® Mind Moments® またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

15:57
 
シェア
 

Manage episode 380402442 series 3340456
コンテンツは NeurologyLive® Mind Moments® によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、NeurologyLive® Mind Moments® またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:
  • Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.
  • Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.
  • Tom Fuchs, MD, PhD, a research fellow at the MS Center at Amsterdam University Medical Center.
  • Barry Singer, MD, the director and founder of The MS Center for Innovations in Care.
  • Georgina Arrambide, a clinical neurologist in the MS Center of Catalunya.

Want more from the MSMilan, the joint ECTRIMS-ACTRIMS meeting? Click here for all of NeurologyLive®'s coverage of MSMilan 2023.
Episode Breakdown:
  • 1:10 – Joi Williams on expanding the use of biomarkers and the next steps in advancing precision medicine for multiple sclerosis treatment.
  • 2:20 – Voskuhl on the increased research efforts to better understand the links between aging, menopause, and women with MS.
  • 4:30 – Fuchs on the challenges of tracking cognitive decline in multiple sclerosis and improving currently available assessments.
  • 7:50 – Singer on the introduction of biosimilars to MS care, the rigorous approval process they undergo, and the potential benefits they bring to the field.
  • 11:45 – Arrambide on an updated consensus approach to the differential diagnosis of suspected multiple sclerosis, and the red flags clinicians should be aware of during this process.

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
  continue reading

129 つのエピソード

Artwork
iconシェア
 
Manage episode 380402442 series 3340456
コンテンツは NeurologyLive® Mind Moments® によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、NeurologyLive® Mind Moments® またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:
  • Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.
  • Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.
  • Tom Fuchs, MD, PhD, a research fellow at the MS Center at Amsterdam University Medical Center.
  • Barry Singer, MD, the director and founder of The MS Center for Innovations in Care.
  • Georgina Arrambide, a clinical neurologist in the MS Center of Catalunya.

Want more from the MSMilan, the joint ECTRIMS-ACTRIMS meeting? Click here for all of NeurologyLive®'s coverage of MSMilan 2023.
Episode Breakdown:
  • 1:10 – Joi Williams on expanding the use of biomarkers and the next steps in advancing precision medicine for multiple sclerosis treatment.
  • 2:20 – Voskuhl on the increased research efforts to better understand the links between aging, menopause, and women with MS.
  • 4:30 – Fuchs on the challenges of tracking cognitive decline in multiple sclerosis and improving currently available assessments.
  • 7:50 – Singer on the introduction of biosimilars to MS care, the rigorous approval process they undergo, and the potential benefits they bring to the field.
  • 11:45 – Arrambide on an updated consensus approach to the differential diagnosis of suspected multiple sclerosis, and the red flags clinicians should be aware of during this process.

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com.
Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
  continue reading

129 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド